When investigators examined a key trial involving Bayer’s Xarelto, they used a specific monitoring device to track the occurrence of blood clots in trial participants called INRatio. The device was later recalled due to tracking errors.
According to… Read More
A new report released by the Government Accountability Office (GAO) reveals disturbing gaps in the the Food and Drug Administrations (FDA) tracking of drug safety issues, putting patients across the nation at risk.
The January 2016 report details numerous… Read More
Pharmaceutical giant Johnson & Johnson has been ordered to pay a 20-year-old Alabama man $2.5 million for injuries related to Risperdal, the popular antipsychotic drug linked to the development of breasts in young male patients.This trial marks the first… Read More
On Nov. 17, a West Virginia jury decided that Takeda Pharmaceutical Co. would pay $155,000 for destroying information on its diabetes drug, Actos, after jurors concluded that this action prevented plaintiff Richard Myers from proving his claim that the… Read More
Ranbaxy, a generic drug maker, pleaded guilty to federal drug safety violations on Monday and agreed to pay $500 million in fines to resolve claims that it sold subpar drugs and made false statements to the Food and Drug Administration regarding its manufacturing… Read More
The FDA’s withdrawing it approval of Avastin (bevacizumab) to treat breast cancer received major media coverage, including front-page articles in major papers and a lead story on a network newscast. ABC World News (11/18, story 5, 0:35, Muir) reported,… Read More
New research suggests the Food and Drug Administrations efforts to issue safety signals when potential health risks of prescription drugs arise isn't working well to notify the public or guide doctors to alternative medicines.
An article published online… Read More
Yesterday, the Bloomberg News reported, Merck & Co, which paid $4.85 billion to resolve patient lawsuits contending its Vioxx painkiller caused heart attacks, settled claims by New York and Florida alleging the company misled state officials about the… Read More
Amgen, maker of Aranesp and Epogen, has agreed to pay $780 million to settle state and federal investigations for allegedly engaging in a wide variety of illegal marketing practices.According to Amgen, the federal investigations seem to involve marketing,… Read More
Pain medicines routinely taken by millions of people to ease headaches and joint pain may also increase the risk of kidney cancer, researchers said.People who regularly used ibuprofen, sold by Johnson & Johnson (JNJ) as Motrin and Pfizer Inc. (PFE) as… Read More